Free Trial

Alnylam Pharmaceuticals (ALNY) SEC Filings & 10K Form

Alnylam Pharmaceuticals logo
$289.96 +0.96 (+0.33%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$291.15 +1.19 (+0.41%)
As of 05/23/2025 05:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Alnylam Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/13/2025
4:01 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
7:09 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
7:15 AM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/07/2025
10:51 AM
Alnylam Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
03/24/2025
4:00 PM
Alnylam Pharmaceuticals (Filer)
Form DEFA14A
03/24/2025
4:02 PM
Alnylam Pharmaceuticals (Filer)
Form ARS
03/24/2025
3:40 PM
Alnylam Pharmaceuticals (Filer)
Form DEF 14A
03/24/2025
3:13 PM
Alnylam Pharmaceuticals (Subject)
PYOTT DAVID E I (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
3:16 PM
Alnylam Pharmaceuticals (Filer)
Form PRE 14A
03/14/2025
3:16 PM
Alnylam Pharmaceuticals (Issuer)
SCHULMAN AMY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:31 PM
Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:31 PM
Alnylam Pharmaceuticals (Issuer)
Tanguler Tolga (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:31 PM
Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:32 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
1:14 PM
Alnylam Pharmaceuticals (Subject)
Capital Research Global Investors (Filed by)
Form SCHEDULE 13G
02/13/2025
7:31 AM
Alnylam Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2025
7:09 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
3:01 PM
Alnylam Pharmaceuticals (Subject)
Garg Pushkal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2025
3:17 PM
Alnylam Pharmaceuticals (Subject)
SHARP PHILLIP A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:31 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
3:13 PM
Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:20 PM
Alnylam Pharmaceuticals (Issuer)
Fitzgerald Kevin Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:21 PM
Alnylam Pharmaceuticals (Issuer)
Tanguler Tolga (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:21 PM
Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:22 PM
Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:22 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:06 PM
Alnylam Pharmaceuticals (Subject)
Fitzgerald Kevin Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
9:34 AM
Alnylam Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
10/31/2024
7:10 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
7:22 AM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/03/2024
3:11 PM
Alnylam Pharmaceuticals (Issuer)
Hesslein Robert W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:01 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
4:10 PM
Alnylam Pharmaceuticals (Subject)
Greenstreet Yvonne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
8:40 AM
Alnylam Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
08/02/2024
7:01 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
7:22 AM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
7:11 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
7:02 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:40 PM
Alnylam Pharmaceuticals (Subject)
Greenstreet Yvonne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/05/2024
9:24 AM
Alnylam Pharmaceuticals (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SC 13G/A
05/31/2024
6:00 PM
Alnylam Pharmaceuticals (Issuer)
SCHULMAN AMY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)

A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Be ready before the historic gold move. Get Garrett’s Top Four picks now.
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALNY) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners